BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Global Biodefense - ECPv6.17.5.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Global Biodefense
X-ORIGINAL-URL:https://globalbiodefense.com
X-WR-CALDESC:Events for Global Biodefense
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20190310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20191103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20200308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20201101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20210314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20211107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Los_Angeles
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20190310T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20191103T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20200308T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20201101T090000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0800
TZOFFSETTO:-0700
TZNAME:PDT
DTSTART:20210314T100000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0700
TZOFFSETTO:-0800
TZNAME:PST
DTSTART:20211107T090000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:America/Chicago
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20190310T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20191103T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20200308T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20201101T070000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0600
TZOFFSETTO:-0500
TZNAME:CDT
DTSTART:20210314T080000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0500
TZOFFSETTO:-0600
TZNAME:CST
DTSTART:20211107T070000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20190331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20191027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20200329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20201025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20211031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200424
DTEND;VALUE=DATE:20200425
DTSTAMP:20200222T220028Z
CREATED:20200222T215710Z
LAST-MODIFIED:20200222T220028Z
UID:40125-1587686400-1587772799@globalbiodefense.com
SUMMARY:Quickfire Challenge Applications Due: JLABS Pediatric Influenza Innovations
DESCRIPTION:Innovators within the fields of pediatric oncology\, pediatric surgery and influenza are invited to submit innovative ideas for a total of up to $150\,000 in grant funding; one year of residency at JLABS @ Washington\, DC with the use of a bench\, workstation\, and access to the JLABS @ Washington\, DC community; and mentorship from experts at the Johnson & Johnson Family of Companies. \nThe submission deadline is 24 April 2020. Please visit the JLABS website for more information.
URL:https://globalbiodefense.com/event/quickfire-challenge-applications-due-jlabs-pediatric-influenza-innovations/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200503
DTEND;VALUE=DATE:20200507
DTSTAMP:20200430T163052Z
CREATED:20190907T221152Z
LAST-MODIFIED:20200430T163052Z
UID:30271-1588464000-1588809599@globalbiodefense.com
SUMMARY:[CANCELLED] ASM Clinical Virology Symposium 2020
DESCRIPTION:“After careful consideration\, ASM’s Clinical Virology Symposium will not be held May 3-6\, 2020. Based on the U.S. Centers for Disease Control and Prevention’s recent recommendation against holding gatherings with 50 or more people for the next eight weeks\, we believe this is the responsible decision and in the best interest of our community.” \nThe 2020 ASM Clinical Virology Symposium will be held May 3–6 in West Palm Beach\, Florida. \nSave the date! Agenda items will be updated as the meeting dates approach. \nThis annual conference covers the latest on microbiome-virome interactions\, RNA sequencing for viral diagnosis\, the challenges and opportunities for a universal influenza vaccine\, and more. \nWatch on demand these industry workshops from the 2019 ASM Clinical Virology Symposium: \n\nDetection of Influenza and Other Respiratory Viruses With The Panther Fusion® Assays\nKathleen Stellrecht; Albany Medical Center\nAddressing the Challenges in the Diagnosis of Lower Respiratory Tract Infections:  The BioFire FilmArray Pneumonia Panel​ ​\nChristine C. Ginocchio; bioMerieux/BioFire\nBioFire Pneumonia Panel: Preparation\, Validation\, and Go Live \nRaul Benavides; Baylor Univeristy Medical Center (Dallas)\nMultiCenter Clinical Trial Study of the Sentosa® SQ HIV Genotyping Assay – A Next Generation Sequencing Test \nBelinda Yen-Lieberman; Cleveland Clinic\nOur Validation Experience: Augusta HIV Map \nRavindra Kolhe; Medical College of Georgia Augusta University\nFilm Array Pneumonia Panel Finding the Best Fit \nSusan Whittier; Columbia University Irving Medical Center\nGetting It Fast vs Getting It Right: Clinician Perspective \nMadison Orsburn; Millard Henry Clinic\nPCR is Better Than RIDT. IDSA Says So – Laboratory Perspective\nGregory Berry; Northwell Health Labs and Long Island Jewish Medical Center\nLaboratory Diagnosis of Bordetella Infections: Rapid\, Direct Detection and Differentiation of B. Pertussis and B. Parapertussis \nJim Dunn; Texas Children’s Hospital\nRapid Detection of Varicella Zoster Virus Central Nervous System Infections\nPreeti Pancholi; The Ohio State University\n\nVisit the 2020 ASM Clinical Virology Symposium website for the latest information.
URL:https://globalbiodefense.com/event/asm-clinical-virology-symposium-2020/
LOCATION:West Palm Beach\, West Palm Beach\, FL\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200520T110000
DTEND;TZID=America/Los_Angeles:20200520T123000
DTSTAMP:20200513T135220Z
CREATED:20200513T135220Z
LAST-MODIFIED:20200513T135220Z
UID:45402-1589972400-1589977800@globalbiodefense.com
SUMMARY:COVID-19 and the Impact on Communities of Color: Our Nation’s Inequities Exposed
DESCRIPTION:The webinar will highlight the disproportionate health and economic impacts the pandemic is having on communities of color and the short- and long-term efforts needed to advance equity in the response to and recovery from the COVID-19 pandemic and future public health emergencies. There will also be a focus on recent federal legislation and state actions in response to COVID-19.
URL:https://globalbiodefense.com/event/covid-19-and-the-impact-on-communities-of-color-our-nations-inequities-exposed/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200528
DTEND;VALUE=DATE:20200530
DTSTAMP:20200206T193045Z
CREATED:20200206T192643Z
LAST-MODIFIED:20200206T193045Z
UID:38922-1590624000-1590796799@globalbiodefense.com
SUMMARY:The Critical Public Health Value of Vaccines in the Age of Pandemics - A Workshop
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine Board on Global Health will host a 1.5-day public workshop May 28-29 that will examine the current state of vaccine preventable diseases and the impact of vaccine access and hesitancy globally\, and the multidimensional drivers and impacts of declining vaccine confidence. \nThis workshop will explore health systems\, research opportunities\, communication strategies\, and policies that could be considered to address access\, perceptions\, attitudes\, and behaviors toward vaccination. \nSpecifically\, this workshop will feature invited presentations and discussions on the following topics: \n• The global impact of declining immunization rates on vaccine-preventable diseases from lack of access and confidence;\n• Trends and indicators to monitor attitudes surrounding vaccine safety and efficacy\, including a focus on regional and cultural differences;\n• The complex determinants of vaccination that hinder or promote vaccine uptake;\n• The role of health systems and professionals in improving access\, influencing vaccine behavior\, protecting at-risk communities from vaccine-preventable disease outbreaks\, and preserving and building confidence in immunization strategies and practices;\n• The role of media\, anti-vaccine networks\, and online misinformation in reinforcing anxieties about vaccine safety and drivers of vaccine hesitancy;\n• Strategies to enhance community-based approaches and community engagement efforts for improving access and reducing vaccine hesitancy;\n• Communication approaches that would help assuage anxieties about vaccine safety and strengthen public trust in science and health professionals;\n• The ethics and effectiveness of legislation that aim to address vaccine hesitancy; and\n• Potential priority actions as well as partnerships and collaborations among policy makers\, health professionals\, national and international health organizations\, parents\, and community groups to increase immunization access and vaccine confidence.
URL:https://globalbiodefense.com/event/the-critical-public-health-value-of-vaccines-in-the-age-of-pandemics-a-workshop/
CATEGORIES:Workshop
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Los_Angeles:20200604T140000
DTEND;TZID=America/Los_Angeles:20200604T160000
DTSTAMP:20200605T214039Z
CREATED:20200527T213856Z
LAST-MODIFIED:20200605T214039Z
UID:46255-1591279200-1591286400@globalbiodefense.com
SUMMARY:COVID-19 Testing and Testing Related Activities with CDC Experts
DESCRIPTION:On Thursday June 4th at 2:00 pm\, the National Association of Rural Health Clinics will be hosting a webinar with experts from the CDC who will be talking about COVID-19 testing and testing related activities. \n\nExperts will talk about the actual testing process\, best practices for collecting samples\, how to align with state officials for more state-specific information and much more. There will also be ample time built into the session for questions from the audience. This webinar is free and open to all. Please feel free to share this information with others whom you think might benefit from participating in this webinar.
URL:https://globalbiodefense.com/event/covid-19-testing-and-testing-related-activities-with-cdc-experts/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200609
DTEND;VALUE=DATE:20200611
DTSTAMP:20200609T170801Z
CREATED:20200527T162939Z
LAST-MODIFIED:20200609T170801Z
UID:46303-1591660800-1591833599@globalbiodefense.com
SUMMARY:APG Advance Planning Briefing to Industry 2020
DESCRIPTION:The Aberdeen Proving Ground (APG) Advance Planning Briefing to Industry (APBI) and Technological Expo\, will be held virtually on 9-10 June 2020\, in lieu of being hosted live at APG\, MD. \nThe goal of the APG APBI is to provide industry with networking opportunities for both large and small businesses. The APBI will describe potential future contracting opportunities for mission areas that focus on: \n\nChemical and Biological Defense\nCommand\, Control\, Communications\, Computers\, Cyber\, Intelligence\, Surveillance\, and Reconnaissance\nResearch and Development\nTest and Evaluation\nAPG Garrison\n\nThe APG APBI will identify potential contracting opportunities that are aligned with the roadmaps of each respective organization\, specifically focusing on Fiscal Years 2021–2022. The Government will not hear formal bids from industry\, as the purpose of the APBI is for the Government to brief upcoming opportunities to industry to help it better understand Army capability requirements and shape its internal development efforts. \nDAY ONE \n0730–0830 Microsoft Teams Setup\n0830–0845 Welcome Remarks by MG Kilgo\n0850–0950 Army Contracting Command-Aberdeen Proving Ground\n0955–1125 Army Contracting Command-Aberdeen Proving Ground: Role of Division Chiefs\n1130–1245 Communications-Electronics Command Defense Logistics Agency-Aberdeen Proving Ground\n1330–1445 Program Executive Office Command Control Communications-Tactical & Network Cross-Functional Team\n1450–1520 Joint Program Executive Office for Chemical\, Biological\, Radiological and Nuclear Defense  Click to download slides for JPEO-CBRND presentation \nDAY TWO \n0730–0830 Microsoft Teams Setup\n0830–0930 Program Executive Office for Intelligence\, Electronic Warfare & Sensors\n0935–1005 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: C5 OTA Consortium Overview\n1010–1040 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: Multi-Domain Sensing System Contract Strategy Overview\n1045–1115 Program Executive Office for Intelligence\, Electronic Warfare & Sensors: PM\, Electronic Warfare & Cyber 21 Strategic Planning Guidance\n1120–1150 Combat Capabilities Development Command\n1155–1225 Combat Capabilities Development Command-CMOSS\n1230–1300 Army Test and Evaulation Command\n1305–1335 A Message from the Office of Small Business Programs\n1340–1410 APG Garrison\n1415–1445 Closing Remarks by MG Kilgo \nThe APG APBI will be unclassified and open to all interested contractors\, large and small businesses\, and academia\, as well as other Government stakeholders. There is no registration required for this event. \nIf you or your company has already purchased a ticket for APBI or reserved a table for the 2020 Team APG Tech Expo\, please contact MissionTix directly for a refund. MissionTix contact information is: 888-996-4774 or help@missiontix.com.
URL:https://globalbiodefense.com/event/apg-advance-planning-briefing-to-industry-2020/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Government Hosted,Industry Day,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/apg-abpi-cbrne-2020.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200616T100000
DTEND;TZID=America/New_York:20200616T120000
DTSTAMP:20200709T194433Z
CREATED:20200609T193108Z
LAST-MODIFIED:20200709T194433Z
UID:46622-1592301600-1592308800@globalbiodefense.com
SUMMARY:COVID-19 Effects on the Food and Agricultural System
DESCRIPTION:The Board on Agriculture and Natural Resources (BANR) of the National Academies of Science\, Engineering\, and Medicine hosted a webinar on Friday\, June 19 from 10:00 – Noon EDT with a virtual panel discussion on COVID 19 effects on the food and agricultural system\, which has experienced severe stress from a combination of factors. Workers’ health has been placed at risk\, producers have lost markets\, and animals and crops have been sacrificed. Meanwhile\, food prices are on the rise and unemployed Americans have turned in greater numbers than ever to overstressed food banks. A panel of distinguished participants in the food and agricultural system offered perspectives on the impacts and how we can learn from them. \nInvited perspectives include: \n\nA.G. Kawamura\, Owner\, Orange County Produce\, and former Secretary of the California Department of Food and Agriculture (2003-2010)\nTom Vilsack\, President and CEO\, U.S. Dairy Export Council\, and former United States Secretary of Agriculture (2009 – 2017)\n\nThe session was moderated by BANR Chairman\, Chuck Rice (Kansas State University). Members of the Board on Agriculture and Natural Resources lead with questions to the presenters\, and the public was able to type in questions to be asked by the moderator. \nVisit NASEM’s website to register.
URL:https://globalbiodefense.com/event/covid-19-effects-on-the-food-and-agricultural-system/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://vimeo.com/430827259
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200617
DTEND;VALUE=DATE:20200618
DTSTAMP:20200520T204211Z
CREATED:20200520T204211Z
LAST-MODIFIED:20200520T204211Z
UID:45697-1592352000-1592438399@globalbiodefense.com
SUMMARY:Biotechnology for Materiel and Defense Symposium
DESCRIPTION:The Biotechnology for Material and Defense Symposium virtual event will be hosted by the National Defense Industrial Association on June 17\, 2020. \nRecent advances in Synthetic Biology\, Biotechnology\, and their supporting infrastructure—biodesign\, automation\, artificial intelligence\, and data analytics—are affording transformational impacts beyond traditional opportunity spaces to produce natural polymers and composites\, synthesize new molecules for coatings and resins\, and ‘grow’ structural materials such as leathers and foams. \nFuture capabilities such as biosensors and nano-structure material production are on the cusp of implementation. The far future promises the ability for in-situ production\, self-healing\, and more. This ability to harness nature’s processes to produce molecules and materials in a sustainable way has the potential to not only have a positive impact on the environment and domestic manufacturing but also radically change how we design\, build\, maintain\, and support our troops. \nPlease visit the NDIA’s Biotechnology for Material and Defense Symposium website for more information and to register. \n 
URL:https://globalbiodefense.com/event/biotechnology-for-materiel-and-defense-symposium/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200618
DTEND;VALUE=DATE:20200623
DTSTAMP:20200430T162843Z
CREATED:20190907T224306Z
LAST-MODIFIED:20200430T162843Z
UID:30282-1592438400-1592870399@globalbiodefense.com
SUMMARY:[CANCELLED] ASM Microbe 2020
DESCRIPTION:Update from ASM on March 30\, 2020\nAfter much thoughtful discussion\, the American Society for Microbiology Board of Directors has made the difficult decision to cancel ASM Microbe 2020\, scheduled for June 18-22\, 2020\, in Chicago\, Ill. \nASM Microbe 2020 will be held 18-22 June 2020 in Chicago\, Illinois. \nSave the date! More details will be posted as the event draws closer. \nASM Microbe 2020\, sponsored by the American Society for Microbiology\, showcases the best microbial sciences in the world\, and provides a one-of-a-kind forum to explore the complete spectrum of microbiology from basic science to translation and application. \nThe event allows scientists to showcase research to the world of microbial scientists and delve into scientific interests and specialties with sessions in core specialty tracks. \nLearn more: http://bit.ly/ASMmicrobe2020 \n 
URL:https://globalbiodefense.com/event/asm-microbe-2020/
LOCATION:TBA – Chicago\, Chicago\, IL\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200628
DTEND;VALUE=DATE:20200703
DTSTAMP:20200430T163909Z
CREATED:20191220T164248Z
LAST-MODIFIED:20200430T163909Z
UID:35676-1593302400-1593734399@globalbiodefense.com
SUMMARY:[CANCELLED] CSTE Annual Conference 2020
DESCRIPTION:For attendees that have already registered for the 2020 Annual Conference and booked hotel accommodations through CSTE’s official housing provider\, Orchid Events\, no action is required on your part. Your meeting registration will automatically be cancelled\, and a full refund will be issued via your original payment method within 30 days.  \nThe Council of State and Territorial Epidemiologists will host the CSTE Annual Conference from June 28 – July 2\, 2020 in Seattle\, Washington. \nThis event is attended by more than 1\,700 public health epidemiologists from across the country and will include workshops\, plenary sessions with leaders in the field of public health\, oral breakout sessions\, roundtable discussions\, and poster presentations. \nConference attendees meet and share their expertise in surveillance and epidemiology as well as best practices in a broad range of areas including informatics\, infectious diseases\, substance use\, immunizations\, environmental health\, occupational health\, chronic disease\, injury control\, and maternal and child health. \nPlease visit the CSTE 2020 website for more information and to register.
URL:https://globalbiodefense.com/event/cste-annual-conference-2020/
LOCATION:Seattle\, Seattle\, WA\, United States
CATEGORIES:Conference
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200629T133000
DTEND;TZID=America/New_York:20200629T143000
DTSTAMP:20200624T201831Z
CREATED:20200624T201628Z
LAST-MODIFIED:20200624T201831Z
UID:46424-1593437400-1593441000@globalbiodefense.com
SUMMARY:COVID-19\, Systemic Racism\, and the Responses of HBCUs: A Virtual Town Hall Discussion
DESCRIPTION:The National Academies of Sciences\, Engineering and Medicine Board on Higher Education and Workforce will host a virtual town hall on Jun 29\, 2020 to discuss COVID-19\, Systemic Racism\, and the Responses of HBCUs. \nHistorically Black Colleges and Universities (HBCUs) are among the nation’s most vital and vibrant institutions\, serving the educational needs of hundreds of thousands of students\, advancing the full spectrum of human knowledge\, and invigorating the cultural\, social\, and economic horizons of the regions they serve. And today\, these universities are at the forefront of the fight against COVID-19\, researching treatments\, keeping their states and communities informed\, and treating patients at academic medical centers.  They are also at the forefront of the nation’s struggles against institutionalized discrimination\, systemic inequality\, and anti-Black racism that are being brought to bear every day in the forms of demonstrations and advocacy in most U.S. communities. \nHow have HBCUs responded to the COVID-19 pandemic and to the recent events surrounding the murder of George Floyd?  As HBCU presidents look toward resuming in-person classes in the fall\, what have they learned from the COVID-19 crisis\, how will their institutions evolve as a result\, and what might that mean for the future of HBCUs in America?  How will HBCUs adapt to the serious financial challenges likely to arise in states and the nation in the months ahead as a consequence of COVID-19? What are HBCU campus leaders doing in preparation for a stronger and higher-profile role in terms of advocacy and leadership in directly addressing anti-Black racism in this country? \nPlease join the presidents of three of the nation’s premier HBCUs as they discuss COVID-19 and issues of racial injustice. This event is hosted by the National Academies’ Board on Higher Education and Workforce and Issues in Science and Technology and sponsored by the Kresge Foundation and the U.S. Department of Defense HBCU/MI Program. \nSpeakers include: \n\nMakola M. Abdullah\, President of Virginia State University\nMary Schmidt Campbell\, President of Spelman College\nC. Reynold Verret\, President of Xavier University of Louisiana\n\nModerated by Gilda Barabino\, President-elect of Olin College of Engineering \nPlease contact John Veras (jveras@nas.edu) for questions.
URL:https://globalbiodefense.com/event/covid-19-systemic-racism-and-the-responses-of-hbcus-a-virtual-town-hall-discussion/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/covid-19-systemic-racism-hbcu-black-colleges-nasem.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200702
DTEND;VALUE=DATE:20200703
DTSTAMP:20200211T231336Z
CREATED:20200211T230408Z
LAST-MODIFIED:20200211T231336Z
UID:39295-1593648000-1593734399@globalbiodefense.com
SUMMARY:Deadline for NIBIB Technology Accelerator Challenge: Handheld Diagnostics
DESCRIPTION:NIH Technology Accelerator Challenge: Non-invasive Diagnostic Technologies for Global Health \nThis challenge seeks designs for non-invasive technology platforms to diagnose sickle cell disease\, malaria\, and anemia. While not constrained to any specific technology\, the inspiration for this challenge comes from the widespread availability of mobile phones and the potential for mobile phone-linked sensor technologies to non-invasively detect changes in the blood and vasculature associated with these treatable diseases. \nKey Dates\nRelease Date: January 31\, 2020\nEstimated Competition Opening Date: March 2\, 2020\nEstimated Competition Closing Date: July 2\, 2020 \nRead more about this opportunity in Funding News. \n  \nGlobal Biodefense provides this information as a courtesy. Information is subject to change. Please check the funding opportunity sponsor website to verify the most current status.
URL:https://globalbiodefense.com/event/deadline-for-nibib-technology-accelerator-challenge-handheld-diagnostics/
LOCATION:Global Biodefense Calendar
CATEGORIES:Deadlines
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200702T110000
DTEND;TZID=America/New_York:20200702T123000
DTSTAMP:20200624T194613Z
CREATED:20200624T194613Z
LAST-MODIFIED:20200624T194613Z
UID:46421-1593687600-1593693000@globalbiodefense.com
SUMMARY:The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19
DESCRIPTION:The National Academies Board on Chemical Sciences and Technology will convene a webcast meeting on July 2\, 2020 to discuss The U.S. Chemical Supply Chain: Vulnerabilities Highlighted by COVID-19. \nThroughout the COVID-19 pandemic\, the chemical industry in the United States has maintained operating status and continues to be at the forefront of worker safety. Despite these achievements\, the pandemic exposed some of the vulnerabilities in the chemical industry’s supply chain. \nWith an increased demand for chemical products\, such as isopropyl alcohol for the production of hand sanitizer\, the United States has seen firsthand the inflexibility of the supply chain to increase or alter production. The “just-in-time” manufacturing approach that many companies previously adopted to maximize efficiency and lower costs has now presented the industry with production challenges and raises the question of how demand can be met if a disruption to the supply chain occurs. Also of note are the specialty chemical and pharmaceutical industries\, which are increasingly vulnerable as they have outsourced many of their operations overseas. \nIn the event of a global disruption or a localized disruption unique to the point of origin\, the United States risks not being able to obtain the products it critically needs—such as personal protective equipment\, medications\, and medical equipment—as has occurred in the case of COVID-19. \n This webinar\, hosted by the Chemical Sciences Roundtable\, will aim to highlight these two vulnerabilities in the supply chain: the inelasticity of the chemical supply chain and the risks posed by the overseas manufacturing of specialty and pharmaceutical chemicals. \nSpeakers include: \n\nDr. David Bem\, VP of Science and Technology and CTO at PPG Industries\, Inc.\nDr. T. Kevin Swift\, Chief Economist at American Chemistry Council\nDr. Ron Piervincenzi\, CEO of United States Pharmacopeia\n\nA recording of the webinar will be made available after the event. Click here to register for this event.
URL:https://globalbiodefense.com/event/the-u-s-chemical-supply-chain-vulnerabilities-highlighted-by-covid-19/
LOCATION:Virtual-Webcast
CATEGORIES:Conference,Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/06/chemical-sciences-roundtable-nasem-covid-19.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200721T100000
DTEND;TZID=America/New_York:20200721T150000
DTSTAMP:20200709T183244Z
CREATED:20200709T183155Z
LAST-MODIFIED:20200709T183244Z
UID:46618-1595325600-1595343600@globalbiodefense.com
SUMMARY:COVID Complexities: Converging Threats\, Fractured Resources
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on July 21\, 2020 to discuss “COVID Complexities: Converging Threats\, Fractured Resources”. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic has taken the lives of more than 100\,000 Americans and damaged the Nation’s economy. As the country reopens\, the disease threatens the public\, now and into the foreseeable future. Federal support for state\, local\, tribal and territorial preparedness and biosurveillance will be crucial to addressing further spread of COVID-19. The Commission intends to address national policy and resource needs for response to and recovery from this crisis. \nSpeakers include: \nJared Moskowitz – Director\, Florida Division of Emergency Management \nAlexis Madrigal – Co-Founder\, The COVID Tracking Project\, and Staff Writer\, The Atlantic \nDavid Mitchell – President\, International Association of Emergency Medical Services Chiefs \nSpeakers will discuss the potential for compoundment of the biological threat\, disease-tracking needs\, hospital preparedness\, and emergency management challenges. \nPlease visit the Bipartisan Commission on Biodefense website to register for this free event.
URL:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:https://globalbiodefense.com/event/covid-complexities-converging-threats-fractured-resources/
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200722T140000
DTEND;TZID=America/New_York:20200722T163000
DTSTAMP:20200709T212451Z
CREATED:20200709T212352Z
LAST-MODIFIED:20200709T212451Z
UID:46694-1595426400-1595435400@globalbiodefense.com
SUMMARY:Next Steps for Functional Genomics: A Workshop and Proceedings Release
DESCRIPTION:The National Academies of Sciences\, Engineering\, and Medicine (NASEM) will convene in a virtual meeting open to the public on July 22\, 2020 to unveil and summarize written proceedings a previous workshop on the future of functional genomics research. \nDuring this proceedings release\, you will have the opportunity to hear from Gene Robinson and Lauren O’Connell\, who were members of the workshop planning committee\, about important insights that were gained over the course of the workshop. \nThe workshop itself was held in February in Washington\, DC\, and included speakers\, panels\, and interactive sessions\, that explored the scientific advancements needed to utilize functional genomics to solve societal problems in areas such as conservation\, evolutionary studies\, agriculture\, energy\, defense\, human health\, and other sectors. \nOver the course of the workshop speakers and participants looked to address the current state of the science\, what lessons have been learned thus far\, what current impediments there are to further progress\, and areas where additional investments could help move the field forward. Importantly\, the workshop served as a platform for discussion within the functional genomics community. \nPlease visit the NASEM website to register. \n 
URL:https://globalbiodefense.com/event/next-steps-for-functional-genomics-a-workshop-and-proceedings-release/
CATEGORIES:Conference,Webinar-Webcast,Workshop
LOCATION:https://nasem.zoom.us/webinar/register/WN_HRB5dQrxRaq16gYVKyZnmA
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20200727
DTEND;VALUE=DATE:20200731
DTSTAMP:20191225T203815Z
CREATED:20191225T203815Z
LAST-MODIFIED:20191225T203815Z
UID:35853-1595808000-1596153599@globalbiodefense.com
SUMMARY:Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens
DESCRIPTION:The FDA and the University of Texas Medical Branch\, Galveston National Laboratory (UTMB) are sponsoring an annual training course 27-30 July 2020 on how to meet good laboratory practice (GLP) requirements in biosafety level (BSL)-4 facilities. \nThe event will be hosted at the National Ebola Training and Education Center in Omaha\, Nebraska. \nThis  course offers a unique opportunity for the regulatory and scientific communities to discuss complex issues in an interactive environment and identify and share best practices for ensuring nonclinical data quality and integrity in BSL-4 facilities. \nPurpose of course\nThe purpose of this unique educational course is to provide a learning environment that: \n\nPromotes collaboration\nProvides tools for conducting clinical studies\nEnhances mutual understanding of clinical\, scientific\, and regulatory complexities\, and\nPromotes the data quality and integrity derived from these regulated studies.\n\nA heightened awareness of the complexities and uniqueness of high- and maximum-containment environments for high-consequence pathogens is the first step in initiating a dialog to find solutions for the planning and execution of studies where data generated will be used to support a regulatory decision. The result is a better-prepared cohesive community of clinical\, scientific\, and regulatory experts mutually engaged in\, and committed to\, the development\, research\, and approval of medical countermeasures for high-consequence pathogens. \nProfessionals who have experience with high-consequence pathogen clinical trials are encouraged to register\, including: \n\nPhysicians\nScientists\nPrincipal investigators\nPhysician assistants\nNurses and nurse practitioners\nPharmacists\nClinical laboratorians\nClinical research staff and clinical monitors\nRegulators and regulatory reviewers\nPolicy-makers\nIRB professionals\nIndustry sponsors\n\nCourse objectives and curriculum\nObjectives\n\nFormulate solutions to regulatory\, operational\, and cultural challenges for the conduct of clinical trials of medical countermeasures for high-consequence pathogens\nIdentify and mitigate risks to data quality and integrity\nResolve complexities of performing clinical trials in biocontainment / barrier nursing environment under good clinical practices (GCPs)\nGain experience conducting clinical research tasks in a mock biocontainment environment while wearing high-level personal protective equipment (PPE)\n\nCourse curriculum\n\nAddressing cultural and language barriers\nEthical considerations for placebo-controlled studies\nRegulatory expectations\nStudy monitoring\nBarrier nursing challenges\nSample integrity\nProtocol development\nOperationalizing a protocol\nProtocol driven data collection vs. clinical data\nGood documentation practices\nReporting adverse events\nInternational issues\nStakeholder roles and responsibilities\n\nBenefits of attending\n\nAttend this free course and earn continuing education (CE) credits.\nLearn from world-renowned faculty members and subject matter experts.\nApply best practices for clinical trials during an outbreak involving high-consequence pathogens.\nRecognize and prevent potential risks to data quality and integrity.\nEnhance cultural awareness and diversity involving clinical trials in geographic locations where outbreaks caused by high-consequence pathogens are frequent.\n\nAttendees will also learn from integrated scenarios\, case studies based on real-life experiences\, and expert panels\, along with lectures from experts from FDA\, the National Institutes of Health\, the NETEC\, and clinical biocontainment units (BCUs). \nPlease visit the FDA website Achieving Data Quality and Integrity in Clinical Trials Involving High-Consequence Pathogens for more information and UTMB’s Registration Page. \n 
URL:https://globalbiodefense.com/event/achieving-data-quality-and-integrity-in-clinical-trials-involving-high-consequence-pathogens/
LOCATION:National Ebola Training and Education Center (NETEC)\, Omaha\, NE\, United States
CATEGORIES:Training
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T090000
DTEND;TZID=America/New_York:20200923T160000
DTSTAMP:20200922T212137Z
CREATED:20200822T211622Z
LAST-MODIFIED:20200922T212137Z
UID:47153-1600851600-1600876800@globalbiodefense.com
SUMMARY:Leveraging Data Science Approaches to Address Environmental Health Challenges in Africa
DESCRIPTION:Environmental Health challenges in Africa are complex\, involving a broad range of exposures\, including ambient and indoor air pollution\, electronic waste\, heavy metals\, pesticides\, vector-borne pathogens\, and climate change\, and a large proportion of the disease burden in Africa is linked to environmental factors. This session will explore unique aspects and analytic challenges of the various types of environmental health data and will highlight recent data science approaches to characterizing hazardous exposures on the African continent\, connecting environmental exposures to health outcomes\, and reducing the risk of disease connected to the environment. \nModerator:\nGwen Collman\, Acting Deputy Director\, Associate Director for Extramural Research\, National Institute of Environmental Health Sciences \nPanelists:\nKiros Berhane\, Professor and Chair\, Department of Biostatistics\, Mailman School of Public Health\, Columbia University \nCaradee Wright\, Senior Specialist Scientist\, Environment and Health Research Unit\, South African Medical Research Council \nEngineer Bainomugisha\, Associate Professor and Chair\, Department of Computer Science\, School of Computing & IT\, Makerere University \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/leveraging-data-science-approaches-to-address-environmental-health-challenges-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200923T130000
DTEND;TZID=America/New_York:20200923T140000
DTSTAMP:20200920T191330Z
CREATED:20200920T191330Z
LAST-MODIFIED:20200920T191330Z
UID:47120-1600866000-1600869600@globalbiodefense.com
SUMMARY:The Effects of COVID-19 on Latin America and the Economic Outlook
DESCRIPTION:Please join the CSIS Americas Program and the CSIS Economics Program for a discussion on how the Covid-19 pandemic is affecting the outlook in Latin America. The ongoing surge in Covid-19 cases across the region raises questions about the timing of recovery\, adequacy of macroeconomic responses\, and the role of private and official sectors in responding to the unprecedented health and economic crises. This event will explore these issues\, as well as sector-specific outlooks in the wake of the pandemic\, and the outlook for sovereign and corporate debt. \nFeaturing a discussion with Geoffrey Okamoto\, Deputy First Managing Director\, International Monetary Fund. \nFollowed by a panel discussion: \n\nChris Campbell\, Chief Strategist\, Duff & Phelps Institute\nKevin Gallagher\, Professor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\nSamar Maziad\, Vice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\nModerated by Stephanie Segal\, Senior Fellow\, Economics Program\, CSIS \nThis event is made possible thanks to the generous support of the Duff & Phelps Institute. \nFEATURING\n\n\n\nGeoffrey Okamoto\nFirst Deputy Managing Director\, International Monetary Fund\n\n\n\n\n\nSamar Maziad\nVice President and Senior Analyst\, Sovereign\, Moody’s Investors Service\n\n\n\n\n\nKevin Gallagher\nProfessor of Global Development Policy\, Boston University\, and Director of the Global Development Policy Center\n\n\n\n\n\nChristopher Campbell\nChief Strategist\, Duff & Phelps Institute
URL:https://globalbiodefense.com/event/the-effects-of-covid-19-on-latin-america-and-the-economic-outlook/
CATEGORIES:Conference,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T090000
DTEND;TZID=America/New_York:20200924T124500
DTSTAMP:20200922T011659Z
CREATED:20200922T010030Z
LAST-MODIFIED:20200922T011659Z
UID:47128-1600938000-1600951500@globalbiodefense.com
SUMMARY:The Biological Event Horizon: No Return or Total Resilience
DESCRIPTION:A virtual meeting of the Bipartisan Commission on Biodefense will be held on Sep. 24 entitled\, “The Biological Event Horizon: No Return or Total Resilience“. \nThe ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for\, respond to\, and recover from biological threats. Decision makers must consider enhancements to policies and programs to better defend against the next biological threat as the Nation continues to respond to the crisis. COVID-19 will not be the last biological threat we face and it likely will not be the worst as the risk of natural and human-generated threats continues to increase with time. \nAt this meeting\, the Commission intends to address these emerging biological threats and innovative science and technology solutions to address them. \nSpeakers include: \n\nJaime Yassif\, PhD: Senior Fellow\, Global Biological Policy and Programs\, Nuclear Threat Initiative\nSohini Ramachandran\, PhD: Associate Professor of Biology\, Director of Graduate Studies for the Center for Computational Molecular Biology\, Associate Professor of Computer Science\, Brown University\nNita Madhav\, MSPH\, Chief Executive Officer\, President\, and Board Member\, Metabiota\nRepresentative Susan Brooks (R-IN):  Member\, Subcommittee on Health\, Committee on Energy and Commerce\, U.S. House of Representatives\nRepresentative Diana DeGette (D-CO): Chair\, Subcommittee on Oversight and Investigation\, Committee on Energy and Commerce\, U.S. House of Representatives\nKavita M. Berger\, PhD: Director\, Board on Life Sciences\, National Academies of Sciences\nLuciana Borio\, MD: Vice President\, Technical Staff\, In-Q-Tel; Former Director for Medical and Biodefense Preparedness\, National Security Council; Former Assistant Commissioner for Counterterrorism Policy and Director\, Office of Counterterrorism and Emerging Threats\, Office of the Chief Scientist\, FDA; and Former Senior Medical Advisor\, Office of the ASPR\, DHHS\n\nPlease visit the Bipartisan Commission on Biodefense website for more information. \nGlobal Biodefense is not affiliated with the Bipartisan Commission on Biodefense and is providing this listing as a courtesy to the community.
URL:https://globalbiodefense.com/event/the-biological-event-horizon-no-return-or-total-resilience/
CATEGORIES:Policy-Legislative,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200924T130000
DTEND;TZID=America/New_York:20200924T143000
DTSTAMP:20200922T011528Z
CREATED:20200919T010636Z
LAST-MODIFIED:20200922T011528Z
UID:47130-1600952400-1600957800@globalbiodefense.com
SUMMARY:Clearing the Path: Responding to Disasters During a Crisis
DESCRIPTION:The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is convening a diverse group of public-private partners to present\, Clearing the Path: Responding to Disasters During a Crisis\, a virtual discussion for National Preparedness Month\, on September 24\, 2020\, from 1:00 p.m. – 2:30 p.m. EST. \nWhen responding to natural disasters during a crisis\, such as the COVID-19 pandemic\, emergency responders\, hospitals\, and supply chains are working at capacity\, while the next hurricane\, wildfire\, or flood could be around the corner. For communities to adapt and respond to these compounding pressures\, they must understand how technologies can inform risk-based decision making in areas of neighborhood health monitoring\, supply chains\, evacuation planning\, crisis communications\, and information sharing among front-line responders. Innovation in predictive analytics\, modeling and simulation\, and mobility offer new solutions to tackle immediate challenges and prepare for emerging threats. \nTopics of this virtual discussion will include: \n\nUnderstanding how public-private partnerships are accelerating new solutions and business models to prepare for day-to-day emergencies and a national crisis.\nEducating community leaders on how new science and technology applications are enhancing resilience and protecting life-line systems and networks.\nWith increased frequency of new threats\, examining what new tools and policies are available to incentivize collaboration among government\, industry\, and foundations.\nWith communities investing in automated and digital technologies\, asking why this is important and how predictive data sets are changing the way we think about risk and preparedness.\n\nSpeakers include: \n\nDavid Maurstad\, Deputy Associate Administrator\, FEMA\n\n\nDuane Caneva\, Chief Medical Officer\, DHS Countering WMD Office\n\n\nTed Smith\, Ph.D.\, Wastewater Based Epidemiology\, Professor of Environmental Medicine\, University of Louisville and Advisor to Louisville Mayor\, Greg Fischer\n\n\nCatherine Cross\, Deputy Under Secretary\, DHS Science and Technology Directorate (S&T)\n\n\nDavid Corman\, Program Director\, Cyber-Physical Systems and Smart and Connected Communities\, National Science Foundation\n\n\nRichard Seline\, Executive Director\, Accelerate H2O\, Houston\, TX\n\n\nMichel Leonard\, Vice President and Senior Economist\, Insurance Information Institute\n\n\nModerator: David Alexander\, Director of Resilience Research and Partnerships\, DHS S&T\n\nTo register for the National Preparedness Month Virtual Discussion: Clearing the Path: Responding to Disasters During a Crisis\, please register here.
URL:https://globalbiodefense.com/event/clearing-the-path-responding-to-disasters-during-a-crisis/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/national-preparedness-clearing-path-disaster-crisis-response-dhs.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200925T130000
DTEND;TZID=America/New_York:20200925T150000
DTSTAMP:20200922T225747Z
CREATED:20200922T225650Z
LAST-MODIFIED:20200922T225747Z
UID:47168-1601038800-1601046000@globalbiodefense.com
SUMMARY:COVID-19: Current State of the Pandemic
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘COVID-19: Current State of the Pandemic” on 25 September 2020 as part of its virtual webinar series. \nIn this webinar\, NETEC will describe the current pandemic hotspots in the US and globally\, including the epidemiology of the current wave of infections; discuss country-wide testing needs to mitigate and suppress COVID-19 infections; and review the evidence regarding possible re-infections of COVID-19\, and interpret the data behind the newest therapeutic guidelines for COVID-19. \nRegister here to attend the virtual event.
URL:https://globalbiodefense.com/event/covid-19-current-state-of-the-pandemic/
CATEGORIES:Conference,Continuing Education
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T090000
DTEND;TZID=America/New_York:20200929T163000
DTSTAMP:20200922T180748Z
CREATED:20200922T180416Z
LAST-MODIFIED:20200922T180748Z
UID:47143-1601370000-1601397000@globalbiodefense.com
SUMMARY:Pediatric Countermeasures: Children's National - NIAID Partnership Virtual Symposium
DESCRIPTION:A virtual symposium highlighting pediatric COVID-19 and MIS-C pandemic efforts undertaken by the NIAID-Children’s Hospital partnership will take place virtually on 29 September\, 2020. \nThis one day symposium bringing together investigators\, researchers\, and clinicians from the National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital as well as other interested participants from outside institutions\, to discuss the creation\, progress\, and evolution of this first-of-its-kind collaboration between the NIAID at the National Institutes of Health and Children’s National\, a pediatric academic medical center. \nThis year\, the event will highlight the current COVID-19 and MIS-C pandemic\, with a specific focus on the pediatric population. \nHighlighted speakers and topics include: \n\nOverview of SARS-CoV-2: Anthony S. Fauci\, MD (NIAID)\nRole of NCATS in the the SARS-CoV-2 Response: Christopher P. Austin\, MD (NCATS)\nHumoral Immune Response: Jeffrey I. Cohen\, MD (NIAID)\nCellular Response (T and NK Cells): Michael Keller\, MD (Children’s National)\nImmunopathogenesis of MIS-C: Sarah E. Henrickson\, MD\, PhD (CHOP)\nGenomic Factors in SARS-CoV-2: Helen Su\, MD\, PhD (NIAID)\nHealth Disparities and SARS-CoV-2: Akilah Jefferson Shah\, MD\, MSc (UAMS)\nClinical Spectrum of SARS-CoV-2\, Implication for Schools Reopening: Dan M. Cooper\, M.D. (UC Irvine)\nMIS-C and Post SARS-CoV-2 Monitoring in Children: Roberta DeBiasi\, MD\, MS (Children’s National)\nPost SARS-CoV-2 Monitoring in Adults: Michael C. Sneller\, MD (NIAID)\nOverview of Vaccine Candidates: Peter Hotez\, MD\, PhD (Baylor)\nCurrent State of Vaccine Clinical Trials: Julie Ledgerwood\, DO (NIAID)\nOngoing Therapeutic Trials and Treatment Guidelines: Cliff Lane\, M.D. (NIAID)\nSARS-CoV-2 What Comes Next – Societal/Economic Impact: Ezekiel Emanuel\, MD\, PhD (UPenn)\n\nIn 2017\, The National Institute of Allergy and Infectious Diseases (NIAID) and Children’s National Hospital launched a clinical research partnership devoted to protecting and advancing the health of children with allergic\, immunologic\, auto-inflammatory\, and infectious disease through collaborative research and education. This strategic and novel alliance is supported through the Clinical and Translational Science Institute at Children’s National (CTSI-CN). The partnership\, co-led by H. Clifford Lane\, M.D.\, Deputy Director for Clinical Research and Special Projects at NIAID\, and Mark Batshaw\, M.D.\, Executive Vice President and Chief Academic Officer at Children’s National\, holds the mission to generate and apply knowledge to promote the prevention\, diagnosis\, treatment\, and cure of these childhood diseases through its work together. \nFor each area\, designated investigators from each institution are collaborating to design and conduct clinical research studies that will advance prevention strategies\, diagnoses\, treatments\, and cures for the diverse range of pediatric diseases involving the immune system. Many of these studies will include children at high risk for complications related to their underlying disease or to experimental therapeutics and diagnostic tests they receive. Research participants will have the opportunity to be seen at both Children’s National and the NIH Clinical Center in Bethesda\, Maryland. Together\, the two institutions provide comprehensive\, state-of-the-art pediatric clinical support\, infrastructure\, and research capacity. These resources protect the safety of children\, ensure that they receive the highest quality of care\, and offer them the opportunity to participate in cutting-edge clinical research. In addition\, the partnership established joint training opportunities for physician-scientists interested in caring for these children while developing their research expertise in pediatric immunology\, allergic\, and infectious diseases. \nThe collaboration is supported through an NIAID supplement to the Clinical and Translational Science Institute at Children’s National\, which is funded by a Clinical and Translational Science Award from NIH’s National Center for Advancing Translational Sciences to Children’s National Hospital and The George Washington University. \nRegister here. \n 
URL:https://globalbiodefense.com/event/pediatric-countermeasures-childrens-national-niaid-partnership-virtual-symposium/
CATEGORIES:Conference,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/niaid-childrens-national-covid-19-research-countermeasures.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200929T110000
DTEND;TZID=America/New_York:20200929T130000
DTSTAMP:20200922T003739Z
CREATED:20200922T002936Z
LAST-MODIFIED:20200922T003739Z
UID:47124-1601377200-1601384400@globalbiodefense.com
SUMMARY:Preventing Global Catastrophic Biological Risks: 2020 Munich Security Conference Tabletop Exercise Report
DESCRIPTION:NTI will host a report release event on 29 September to review lessons and recommendations from NTI’s 2020 Munich Security Conference Tabletop Exercise\, presenting key recommendations for actions that international stakeholders can take to meaningfully reduce catastrophic biological risks. \nThe virtual event is moderated by Andrew Hebbeler\, Senior Director and Lead Scientist\, NTI Global Biological Policy and Programs. \nSpeakers include: \n\nErnest J. Moniz\, Co-Chair and CEO\, NTI\nElhadj As Sy\, Co-Chair\, Global Preparedness Monitoring Board\nEmily Leproust\, CEO\, Twist Bioscience\nJaime Yassif\, Senior Fellow\, NTI Global Biological Policy and Programs\n\nThe presentations will be followed by Q&A with attendees. \nPlease visit the NTI website for additional information.
URL:https://globalbiodefense.com/event/preventing-global-catastrophic-biological-risks-launch-event-for-ntis-2020-munich-security-conference-tabletop-exercise-report/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:https://zoom.us/webinar/register/WN_UOTGXaUMTguXnxs7ileOTw
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T090000
DTEND;TZID=America/New_York:20200930T160000
DTSTAMP:20200922T212454Z
CREATED:20200922T212454Z
LAST-MODIFIED:20200922T212454Z
UID:47156-1601456400-1601481600@globalbiodefense.com
SUMMARY:Biomedical Informatics and Data Sciences in Africa
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Biomedical Informatics and Data Sciences in Africa‘ on 30 September 2020 as part of the DS-I Africa Virtual Forum series. \nThis session will address emerging opportunities and challenges in the application of Data Science and Informatics technologies in various biomedical domains. It will also highlight some key challenges in the areas of data mining\, data quality\, standards for various types of data\, in addition to addressing how cutting-edge data analytics\, predictive modeling and Machine Learning\, and methods for simulations can advance human health in Africa. \nModerator: \nDarrell Hurt\, National Institute of Allergy and Infectious Diseases\, National Institutes of Health (NIH) \nGeetha Senthil\, National Institute of Mental Health\, NIH\nPanelists:\nAgnes Abdoulaye Banire Diallo\, University of Quebec-Montreal (UQAM) \nElaine Nsoesie\, Boston University \nGeoffrey Siwo\, University of Notre Dame \nDina Machuve\, Nelson Mandela African Institution of Science and Technology \nMoustapha Cisse\, Google AI \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/biomedical-informatics-and-data-sciences-in-africa/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20200930T130000
DTEND;TZID=America/New_York:20200930T143000
DTSTAMP:20200927T191940Z
CREATED:20200827T174326Z
LAST-MODIFIED:20200927T191940Z
UID:47213-1601470800-1601476200@globalbiodefense.com
SUMMARY:DTRA Chemical and Biological Technologies Department: Student Workforce Opportunities
DESCRIPTION:The Defense Threat Reduction Agency’s Chemical and Biological Technologies Department (DTRA-CB) will host a University Engagement Webinar: Student Workforce Opportunities on Wednesday\, Sept. 30\, 2020. \nDuring this webinar\, participants will learn about internships\, scholarships\, fellowships\, postdoctoral and employment opportunities available through the DoD and federal government. \nTopics that will be discussed include: \n\nMore on DTRA-CB’s role as the DoD’s Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD)\nNational Research Council (NRC) Research Associateship (Postdoctoral) Program\nPathways Programs: Pathways Internship Programs\, Recent Graduates Program and the Presidential Management Fellows Program (PMF)\nNavigating USAJOBS for employment opportunities\nScience\, Mathematics\, and Research for Transformation (SMART) Scholarship-for-Service Program benefits\, application deadlines and success stories\n\nLearn more: http://bit.ly/dtracbd-student-workforce
URL:https://globalbiodefense.com/event/dtra-chemical-and-biological-technologies-department-student-workforce-opportunities/
CATEGORIES:Government Hosted,Webinar-Webcast
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/08/defense-threat-reduction-chemical-biological-defense-dtra-cbd-jsto-university-engagement-global-biodefense.jpg
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20201001T100000
DTEND;TZID=Europe/London:20201001T110000
DTSTAMP:20200927T192759Z
CREATED:20200927T192759Z
LAST-MODIFIED:20200927T192759Z
UID:47216-1601546400-1601550000@globalbiodefense.com
SUMMARY:Accelerating Detection of Disease: UKRI Industry Briefing for Life Sciences Sector
DESCRIPTION:The UK Research and Innovation (UKRI)-funded Accelerating Detection of Disease (ADD) program will host a webinar on 1 October 2020 for life science companies to learn more about partnering and investment opportunities. \nOver the next four years the ADD program will recruit five million volunteers to support research intended to improve early detection\, risk stratification\, and early intervention for chronic diseases. \nADD volunteers will provide biological samples and health related data. With their consent\, volunteers’ data will be linked to NHS records\, and ADD will also offer volunteers feedback about their health\, if they choose. Some will be invited to provide repeat samples and join follow-on studies designed to test the potential of new diagnostic tests or treatments\, particularly if they’re at higher risk for certain diseases. \nThe unrivalled depth and detail of the ADD initiative will make it a unique resource for health research. Researchers from across academia and industry will have the chance to work with ADD to conduct studies that could improve the way we detect\, diagnose and treat diseases. \nSpeakers at the seminar include: \n\nAlison Cave\, Accelerating Detection of Disease challenge director at UK Research and Innovation\nAndrew Roddam\, CEO\, Early Disease Detection Research Project UK Ltd\, the charity that runs the ADD programme\nFiona Reddington\, Exec Director of Partnerships\, Early Disease Detection Research Project UK Ltd.\n\nADD is funded by £79 million from UKRI’s Industrial Strategy Challenge Fund which is expected to be matched by funding of up to £160 million from industry.
URL:https://globalbiodefense.com/event/accelerating-detection-of-disease-ukri-industry-briefing-for-life-sciences-sector/
CATEGORIES:Industry Day,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201001T120000
DTEND;TZID=America/New_York:20201001T130000
DTSTAMP:20200923T194149Z
CREATED:20200923T194110Z
LAST-MODIFIED:20200923T194149Z
UID:47182-1601553600-1601557200@globalbiodefense.com
SUMMARY:HDIAC Webinar: Agnostic Compact Demilitarization of Chemical Agents
DESCRIPTION:Join HDIAC Thursday\, October 1\, from 1200 to 1300 EDT for our next webinar presentation titled “Agnostic Compact Demilitarization of Chemical Agents (ACDC).” \nPlease register in advance for the webinar at: https://www.anymeeting.com/PIID=EF54DD81854C3B \nThe safe destruction of chemical warfare agents (CWAs) and organic precursors is a timely\, costly\, and significant challenge for the international community. Today\, for example\, there are no approaches that exploit chemistries that are truly agnostic in terms of the agents that can be processed. Additionally\, current approaches require transport of agents from the storage site to a neutralization site\, which can add significant cost and time to the destruction process. \nDARPA’s ACDC program explored new technologies for neutralization of bulk stores of CWAs and organic precursors at or near the site of storage. ACDC developed and demonstrated the technologies needed to construct a transportable\, prototype system that converts organic compounds into constitutive carbon/nitrogen/phosphorous/sulfur oxides and stable alkali or alkaline earth metal salts. The ACDC system featured chemistries for agent destruction and sequestration of halogens and other components using locally available or easily transportable resources. This webinar describes the DARPA ACDC program and its exploration of neutralization of bulk stores of CWAs and organic precursors at or near the site of storage. \nABOUT THE SPEAKER \nMr. Darrel Johnston manages the Pharmaceutical Program and Pilot Plant Operations section of the Southwest Research Institute which works with government and commercial clients in the areas of drug modeling\, synthesis\, scale-up\, and production.    With reactors up to 200 liters\, he oversees the operation of a pilot plant facility compliant with current Good Manufacturing Practices\, Good Laboratory Practice\, and Drug Enforcement Agency controlled substances as needed.  Projects have included treatment or preventative drugs for cancer\, heart attack\, COVID-19\, EBOV\, SUDV\, MARV\, and poisoning from opioids\, organophosphates\, and cyanide. Mr. Johnston’s chemical demilitarization experience includes construction\, systemization\, start-up\, operations\, and closure phases of chemical warfare agent demilitarization at the Johnston Atoll Chemical Agent Destruction System (JACADS)\, Umatilla Chemical Agent Disposal Facility (UMCDF)\, Pine Bluff Chemical Agent Disposal Facility\, and Newport Chemical Agent Disposal Facility (NECDF).  He facilitated air sampling and analysis for chemical agent BZ\, for the demolition of the BZ Disposal Facility (BZDF) in Pine Bluff\, AR.  Mr. Johnston served as the on-site Laboratory Manager for the JACADS\, UMCDF\, and NECDF facilities and was responsible for leadership and day-to-day operation of the agent and non-agent monitoring systems including the analytical laboratories.  His direct support of demilitarization laboratory operations spanned 17 years from 1990-2008. Mr. Johnston was also the Southwest Research Institute project manager for the Defense Advanced Research Projects Agency (DARPA) Agnostic Compact Demilitarization of Chemicals (ACDC) project.  While serving in this role\, he investigated the use of a diesel engine for the destruction of chemical warfare agents and making use of media such as soil for acid gas scrubbing.
URL:https://globalbiodefense.com/event/hdiac-webinar-agnostic-compact-demilitarization-of-chemical-agents/
CATEGORIES:Webinar-Webcast,Workshop
ATTACH;FMTTYPE=image/jpeg:https://globalbiodefense.com/wp-content/uploads/2020/09/hdiac-webinar-agnostic-compact-demilitarization-chemical-agents.jpg
LOCATION:https://www.anymeeting.com/AccountManager/RegEv.aspx?PIID=EF54DD81854C3B
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201002T130000
DTEND;TZID=America/New_York:20201002T150000
DTSTAMP:20200923T002332Z
CREATED:20200923T002332Z
LAST-MODIFIED:20200923T002332Z
UID:47176-1601643600-1601650800@globalbiodefense.com
SUMMARY:Got Masks? PPE Compliance and Fatigue in First Responder Realms
DESCRIPTION:The National Emerging Special Pathogen Training and Education Center (NETEC) will host ‘Got Masks? PPE Compliance and Fatigue in First Responder Realms‘ on 2 October 2020 as part of its virtual webinar series. \nAre personnel becoming less diligent with PPE? Is there a significant element of PPE fatigue? Do you know what the PPE requirements are when not actively providing patient care? What about PPE requirements in the office\, ambulance\, and firehouse? Join NETEC for a Town Hall meeting and discuss the importance of PPE in the First Responder Environment and learn techniques to deal with PPE fatigue and improve compliance? Submit your questions for the panel during registration and they will be answered during the Town Hall session. \nPlease register here: http://bit.ly/netec-ppe-compliance
URL:https://globalbiodefense.com/event/got-masks-ppe-compliance-and-fatigue-in-first-responder-realms/
CATEGORIES:Webinar-Webcast,Workshop
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201007T090000
DTEND;TZID=America/New_York:20201007T160000
DTSTAMP:20200922T214447Z
CREATED:20200922T214447Z
LAST-MODIFIED:20200922T214447Z
UID:47158-1602061200-1602086400@globalbiodefense.com
SUMMARY:Innovative Approaches to Improve Maternal and Child Health
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Innovative Approaches to Improve Maternal and Child Health‘ on 7 October 2020 as part of the DS-I Africa Virtual Forum series. \nMaternal and child health outcomes in Africa still lag behind the rest of the world despite prioritization as a topic of focus within the United Nations Sustainable Development Goals (SDGs). Partners from  country-level governments\, research institutions\, private sector program funding agencies and non-governmental organizations are involved in various capacities and across disciplines\, implementing activities to reduce the enormous burden of high mortality and morbidity of women and children on the African continent.  Nonetheless\, millions of women and children experience death and severe morbidity each year despite these efforts. In this session we will 1) address the gap in availability of existing databases and collective data focused on pregnancy and the peripartum period; 2) explore emerging use of linked data such as electronic medical records as a tool for conducting research\, analyzing data and creating tools for interventions; and 3) develop concrete recommendations for a strategy to utilize data science to improve maternal and child health outcomes from pre-pregnancy to pregnancy and delivery and throughout the mother and child’s life course. \nIntroductions:\nVesna Kutlesic\, US Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)\, National Institutes of Health (NIH) \nDiana Bianchi\, Director of NICHD\, NIH \nNaveen Rao\, MD\, Senior Vice President & Senior Advisor to the President\, Health Initiative\, The Rockefeller Foundation \nModerator:\nDenise Russo\, NICHD\, NIH \nPanelists:\nAndre van der Kouwe\, Ph.D.\, Associate Professor in Radiology\, Harvard Medical School\, Assistant in Physics\, Massachusetts General Hospital \nLilla Zöllei\, Ph.D.\, Assistant Professor of Radiology\, Harvard Medical School \nMoses Alobo\, M.D.\, Program Manager\, Grand Challenges Africa Programme at African Academy of Sciences \nAlash’le Abimiku\, Ph.D.\, Professor in Epidemiology & Public Health\, University of Maryland School of Medicine; Executive Director\, International Research Center of Excellence at the Institute of Human Virology-Nigeria \nAmel Ghouila\, Ph.D.\, Bioinformatician\, Capacity Builder\, Pan African Bioinformatics \nTo participate in the discussion and session\, you must register for this DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/innovative-approaches-to-improve-maternal-and-child-health/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20201014T090000
DTEND;TZID=America/New_York:20201014T160000
DTSTAMP:20200922T214817Z
CREATED:20200922T214735Z
LAST-MODIFIED:20200922T214817Z
UID:47160-1602666000-1602691200@globalbiodefense.com
SUMMARY:Using Data Science to Fight COVID-19
DESCRIPTION:The National Institutes of Health will host a virtual learning session entitled ‘Using Data Science to Fight COVID-19‘ on 14 October 2020 as part of the DS-I Africa Virtual Forum series. \nModerator:\nStefan Jaeger\, National Library of Medicine\, National Institutes of Health \nPanelists:\nAgnes Kiragga\, Ph.D.\, Head of Statistics and Data Management Unit and Senior Research Scientist\, Infectious Diseases Institute (IDI)\, Makerere University College of Health Sciences \nNirmal Ravi\, MD\, Ph.D. \nAli H. Mokdad\, Ph.D.\, Professor of Health Metrics Sciences\, the Institute for Health Metrics and Evaluation; Chief Strategy Officer\, Population Health at the University of Washington \nElaine Nsoesie\, Ph.D.\, Assistant Professor of Global Health\, Boston University School of Public Health \nFrank Kagoro\, Ph.D.\, Research Physician\, MORU Tropical Health Network and WorldWide Antimalarial Resistance Network \nTo participate in the discussion and session\, you must register for the DS-I Africa Virtual Forum in advance. All content will also be recorded and posted on this website after each event.
URL:https://globalbiodefense.com/event/using-data-science-to-fight-covid-19/
CATEGORIES:Government Hosted,Webinar-Webcast
LOCATION:
END:VEVENT
END:VCALENDAR